The Sequential Parallel Comparison Model: A Revolution in the Design of Clinical Trials

By  

Psychotherapy and Psychosomatics, Vol. 72, Iss. 3, 2003-04 ,pp. : 113-114

Karger

Access to resources Recommend Favorite

Surrogate end points: when should they be used?

By Molenberghs Geert   Abad Ariel Alonso   van der Elst Wim   Burzykowski Tomasz   Buyse Marc  

Clinical Investigation, Vol. 3, Iss. 12, 2013-12 ,pp. : 1147-1155

Future Science

Access to resources Recommend Favorite

Comparison of sequential rosuvastatin doses in hypercholesterolaemia: a meta-analysis of randomised controlled trials

By Gray Joe   Edwards Steven J.   Lip Gregory Y.H.  

Current Medical Research and Opinion, Vol. 26, Iss. 3, 2010-03 ,pp. : 537-547

Informa Healthcare

Access to resources Recommend Favorite

Should be there specific guidelines to improve reporting of clinical pharmacology trials?

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 2, 2015-08 ,pp. : 177-178

John Wiley & Sons Inc

Access to resources Recommend Favorite

Trials are meaningful for clinical decision making only when their endpoints are valid and comparable

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 5, 2015-05 ,pp. : 1175-1177

John Wiley & Sons Inc

Access to resources Recommend Favorite